Literature DB >> 22268092

Differentiation of hemorrhage from iodinated contrast in different intracranial compartments using dual-energy head CT.

C M Phan1, A J Yoo, J A Hirsch, R G Nogueira, R Gupta.   

Abstract

BACKGROUND AND
PURPOSE: Identification of ICH, particularly after ischemic stroke therapy, is important for guiding subsequent antithrombotic management and is often confounded by contrast staining or extravasations within intracerebral or extra-axial compartments. This study evaluates the accuracy of DECT in distinguishing ICH from iodinated contrast in patients who received contrast via IA or IV delivery.
MATERIALS AND METHODS: Forty patients who had received IA or IV contrast were evaluated using a DECT scanner at 80kV and 140kV to distinguish hyperdensities secondary to contrast staining or extravasation from those representing ICH. A 3-material decomposition algorithm was used to obtain virtual noncontrast images and iodine overlay images. Sensitivity, specificity, and accuracy of DECT in prospectively distinguishing intracranial contrast from hemorrhage within parenchymal, subarachnoid, extra-axial, intraventricular, and intra-arterial compartments were computed using routine clinical follow-up imaging as the standard of reference.
RESULTS: A total of 148 foci of intracranial hyperattenuation were identified. Of these, 142 were correctly classified for the presence of hemorrhage by DECT. The sensitivity, specificity, and accuracy for identifying hemorrhage, depending on the compartment being considered, were 100%, 84.4%-100%, and 87.2%-100%, respectively. The only instances where DECT failed to correctly identify the source of hyperattenuation was in the presence of diffuse parenchymal calcification (n = 5) and a metallic streak artifact (n = 1).
CONCLUSION: After IA and/or IV contrast administration, DECT can accurately differentiate all types of ICH from iodinated contrast without employing any additional radiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22268092      PMCID: PMC8013231          DOI: 10.3174/ajnr.A2909

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

Review 1.  Dual energy CT: preliminary observations and potential clinical applications in the abdomen.

Authors:  Anno Graser; Thorsten R C Johnson; Hersh Chandarana; Michael Macari
Journal:  Eur Radiol       Date:  2008-08-02       Impact factor: 5.315

2.  Dual energy CTA of the supraaortic arteries: technical improvements with a novel dual source CT system.

Authors:  Michael M Lell; Fabian Hinkmann; Emeka Nkenke; Bernhard Schmidt; Peter Seidensticker; Willi A Kalender; Michael Uder; Stephan Achenbach
Journal:  Eur J Radiol       Date:  2009-10-09       Impact factor: 3.528

3.  Energy-selective reconstructions in X-ray computerized tomography.

Authors:  R E Alvarez; A Macovski
Journal:  Phys Med Biol       Date:  1976-09       Impact factor: 3.609

Review 4.  Intracranial hemorrhage associated with revascularization therapies.

Authors:  Pooja Khatri; Lawrence R Wechsler; Joseph P Broderick
Journal:  Stroke       Date:  2007-01-18       Impact factor: 7.914

5.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

6.  Dual-energy CT of the heart for diagnosing coronary artery stenosis and myocardial ischemia-initial experience.

Authors:  Balazs Ruzsics; Heon Lee; Peter L Zwerner; Mulugeta Gebregziabher; Philip Costello; U Joseph Schoepf
Journal:  Eur Radiol       Date:  2008-06-04       Impact factor: 5.315

7.  Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation.

Authors:  Paul Stolzmann; Hans Scheffel; Katharina Rentsch; Thomas Schertler; Thomas Frauenfelder; Sebastian Leschka; Tullio Sulser; Borut Marincek; Hatem Alkadhi
Journal:  Urol Res       Date:  2008-06-11

8.  Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images?

Authors:  Anno Graser; Thorsten R C Johnson; Elizabeth M Hecht; Christoph R Becker; Christianne Leidecker; Michael Staehler; Christian G Stief; Henriette Hildebrandt; Myrna C B Godoy; Myra E Finn; Flora Stepansky; Maximilian F Reiser; Michael Macari
Journal:  Radiology       Date:  2009-06-01       Impact factor: 11.105

9.  The assessment of intracranial bleeding with virtual unenhanced imaging by means of dual-energy CT angiography.

Authors:  Jirí Ferda; Milan Novák; Hynek Mírka; Jan Baxa; Eva Ferdová; Alena Bednárová; Thomas Flohr; Bernhard Schmidt; Ernst Klotz; Boris Kreuzberg
Journal:  Eur Radiol       Date:  2009-07-08       Impact factor: 5.315

10.  Dual energy computed tomography in tophaceous gout.

Authors:  H K Choi; A M Al-Arfaj; A Eftekhari; P L Munk; K Shojania; G Reid; S Nicolaou
Journal:  Ann Rheum Dis       Date:  2008-12-09       Impact factor: 19.103

View more
  51 in total

1.  Hyper-attenuating brain lesions on CT after ischemic stroke and thrombectomy are associated with final brain infarction.

Authors:  F B Cabral; L H Castro-Afonso; G S Nakiri; L M Monsignore; Src Fábio; A C Dos Santos; O M Pontes-Neto; D G Abud
Journal:  Interv Neuroradiol       Date:  2017-09-26       Impact factor: 1.610

2.  Dual-energy CT angiography-derived virtual non-contrast images for follow-up of patients with surgically clipped aneurysms: a retrospective study.

Authors:  Su Young Yun; Young Jin Heo; Hae Woong Jeong; Jin Wook Baek; Hye Jung Choo; Gi Won Shin; Sung Tae Kim; Young Gyun Jeong; Ji Young Lee; Hyun Seok Jung
Journal:  Neuroradiology       Date:  2019-01-25       Impact factor: 2.804

3.  Discrimination of Tumorous Intracerebral Hemorrhage from Benign Causes Using CT Densitometry.

Authors:  Y S Choi; T H Rim; S S Ahn; S-K Lee
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-29       Impact factor: 3.825

4.  Residual Thromboembolic Material in Cerebral Arteries after Endovascular Stroke Therapy Can Be Identified by Dual-Energy CT.

Authors:  A E Grams; M Knoflach; R Rehwald; J Willeit; M Sojer; E R Gizewski; B Glodny
Journal:  AJNR Am J Neuroradiol       Date:  2015-05-21       Impact factor: 3.825

5.  Visualization of joint and bone using dual-energy CT arthrography with contrast subtraction: in vitro feasibility study using porcine joints.

Authors:  Jee Won Chai; Jung-Ah Choi; Ja-Young Choi; Sujin Kim; Sung Hwan Hong; Heung Sik Kang
Journal:  Skeletal Radiol       Date:  2014-01-25       Impact factor: 2.199

6.  Temporal evolution of intraparenchymal hyperdensity after intra-arterial therapy in patients with ischemic stroke: optimal discrimination between hemorrhage and iodinated contrast.

Authors:  O Khalilzadeh; B Sabel; Y Sung; A Parikh; C M Phan; J Dinkel; A J Yoo; J Romero; R Gupta
Journal:  Clin Neuroradiol       Date:  2014-01-30       Impact factor: 3.649

Review 7.  Dual-energy computed tomography (DECT) in emergency radiology: basic principles, techniques, and limitations.

Authors:  Shima Aran; Khalid W Shaqdan; Hani H Abujudeh
Journal:  Emerg Radiol       Date:  2014-03-28

8.  Differentiating intraparenchymal hemorrhage from contrast extravasation on post-procedural noncontrast CT scan in acute ischemic stroke patients undergoing endovascular treatment.

Authors:  Seyedmehdi Payabvash; Mushtaq H Qureshi; Shayaan M Khan; Mahnoor Khan; Shahram Majidi; Swaroop Pawar; Adnan I Qureshi
Journal:  Neuroradiology       Date:  2014-06-13       Impact factor: 2.804

9.  Contrast Extravasation versus Hemorrhage after Thrombectomy in Patients with Acute Stroke.

Authors:  Vivek Yedavalli; Steffen Sammet
Journal:  J Neuroimaging       Date:  2017-05-17       Impact factor: 2.486

10.  The role of head computed tomography imaging in the evaluation of postoperative neurologic deficits in cardiac surgery patients.

Authors:  Claude A Beaty; George J Arnaoutakis; Maura A Grega; Chase W Robinson; Timothy J George; William A Baumgartner; Rebecca F Gottesman; Guy M McKhann; Duke E Cameron; Glenn J Whitman
Journal:  Ann Thorac Surg       Date:  2012-12-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.